How Can the Current Strategies for Helicobacter pylori Eradication Therapy be Improved?Canadian Journal of Gastroenterology and Hepatology - Tập 17 Số B - 2003
Alexander C. Ford, Paul Moayyedi
BACKGROUND: The use of Helicobacter pylori eradication therapy is advocated in
an increasing variety of situations. It is therefore important to optimise
current strategies to eradicate H pylori infectionOBJECTIVES: To define the
optimum dosage, drugs and duration of proton pump inhibitor (PPI) triple
therapy.METHODS: A review of the literature was performed to identify randomized
controlled trial... hiện toàn bộ
Thrombocytopenia in Liver DiseaseCanadian Journal of Gastroenterology and Hepatology - Tập 14 Số D - 2000
Markus Peck‐Radosavljevic
Moderate thrombocytopenia is a frequent finding in cirrhosis of the liver and
well tolerated in most instances. The pathophysiology of thrombocytopenia in
liver disease has long been associated with the concept of hypersplenism, where
portal hypertension was thought to cause pooling and sequestration of all
corpuscular elements of the blood, predominantly thrombocytes in the enlarged
spleen. The c... hiện toàn bộ
Natural History of Nonalcoholic Fatty Liver Disease: Implications for Clinical Practice and an Individualized ApproachCanadian Journal of Gastroenterology and Hepatology - Tập 2020 - Trang 1-10 - 2020
Ivica Grgurević, Kristian Podrug, Ivana Mikolašević, Michał Kukla, Anita Madir, Emmanuel Tsochatzis
Nonalcoholic fatty liver disease (NAFLD) is becoming the most prevalent liver
disease worldwide, associated with epidemics of overweight and resulting
metabolic syndrome (MetS). Around 20–30% of patients with NAFLD develop
progressive liver fibrosis, which is the most important predictor of
liver-related and overall morbidity and mortality. In contrast to classical
understanding, no significant as... hiện toàn bộ
Role of NLRP3 Inflammasome in the Progression of NAFLD to NASHCanadian Journal of Gastroenterology and Hepatology - Tập 2016 - Trang 1-7 - 2016
Xingyong Wan, Chengfu Xu, Chaohui Yu, Youming Li
Nonalcoholic fatty liver disease (NAFLD) has been recognized as a major public
health problem worldwide. Nonalcoholic steatohepatitis (NASH) is an advanced
form of NAFLD that may progress to cirrhosis and hepatocellular carcinoma. The
pathogenesis of disease progression from NAFLD to NASH has not been fully
understood. Immunological mechanisms that have been increasingly recognized in
the disease ... hiện toàn bộ
Postliver Transplant Allograft Reinfection with a Lamivudine‐Resistant Strain of Hepatitis B Virus: Long Term Follow‐upCanadian Journal of Gastroenterology and Hepatology - Tập 12 Số 2 - Trang 125-129 - 1998
Eric M. Yoshida, Mang Ma, Jennifer Davis, Karl Fischer, Norman M. Kneteman, Siegfried R. Erb, D. Lorne Tyrrell, Vincent G. Bain
Lamivudine is a nucleoside analogue with efficacy in the suppression of
hepatitis B viral (HBV) replication. In a previously reported study, lamivudine
was administered to patients with chronic, actively replicating HBV infection
who subsequently underwent liver transplantation. Patients became serum HBV
DNA‐negative in response to lamivudine before transplantation, which was
continued in the post... hiện toàn bộ
Physician Global Assessments or Blood tests do not Predict Mucosal Disease Activity in Ulcerative ColitisCanadian Journal of Gastroenterology and Hepatology - Tập 28 Số 6 - Trang 325-329 - 2014
Mayur Brahmania, Çharles N. Bernstein
BACKGROUND: Mucosal healing has been proposed as the therapeutic end point in
the treatment of patients with ulcerative colitis (UC).OBJECTIVE: To investigate
the relationship between physician global assessment (PGA) and laboratory blood
tests (complete blood count, ferritin, C-reactive protein, albumin) and
endoscopic findings in UC to determine whether they could be adequate surrogates
for endo... hiện toàn bộ